← Back to Search

Stem Cell Transplant

NiCord® for Blood Cancers

Phase 1 & 2
Waitlist Available
Led By Mitchell Horwitz, MD
Research Sponsored by Gamida Cell ltd
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 42 days
Awards & highlights
No Placebo-Only Group

Summary

A Study Evaluating the Safety and Efficacy of Transplantation of a single cord blood unit (CBU) of NiCord®, umbilical cord blood-derived Ex Vivo Expanded Stem and Progenitor Cells in Patients with Hematological Malignancies.

Eligible Conditions
  • Leukemia
  • Blood Cancers
  • Myelodysplastic Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~42 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 42 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Engraftment

Side effects data

From 2018 Phase 1 & 2 trial • 36 Patients • NCT01816230
47%
Infection
36%
Hypertension
31%
GvHD
25%
Decreased appetite
22%
Hematologic Malignancy
17%
Hyperglycemia
14%
Leukemia recurrent
100%
80%
60%
40%
20%
0%
Study treatment Arm
NiCord®

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: NiCord®Experimental Treatment1 Intervention
NiCord® is a stem/progenitor cell based product composed of ex vivo expanded allogeneic UCB cells.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NiCord®
2013
Completed Phase 2
~50

Find a Location

Who is running the clinical trial?

Gamida Cell ltdLead Sponsor
8 Previous Clinical Trials
254 Total Patients Enrolled
Mitchell Horwitz, MDPrincipal InvestigatorDuke University
13 Previous Clinical Trials
498 Total Patients Enrolled
~3 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top